United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Oct 22, 2026 · Filed Oct 23, 2026

On Oct 22, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$583.38 for US$5.54M under a trading plan, leaving 324,443 shares. Filed Oct 23, 2026 (Form 4).

Sold
9,500 shares
Price
US$583.38 average (US$562.97 to US$590.40)
Value
US$5.54M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 22, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Oct 22, 2026Common StockSale74US$562.97333,869Indirect
Oct 22, 2026Common StockSale110US$563.98333,759Indirect
Oct 22, 2026Common StockSale160US$565.09333,599Indirect
Oct 22, 2026Common StockSale160US$570.08333,439Indirect
Oct 22, 2026Common StockSale160US$571.77333,279Indirect
Oct 22, 2026Common StockSale40US$573.39333,239Indirect
Oct 22, 2026Common StockSale130US$575.32333,109Indirect
Oct 22, 2026Common StockSale190US$576.80332,919Indirect
Oct 22, 2026Common StockSale280US$577.28332,639Indirect
Oct 22, 2026Common StockSale160US$578.59332,479Indirect
Oct 22, 2026Common StockSale160US$579.69332,319Indirect
Oct 22, 2026Common StockSale360US$581.03331,959Indirect
Oct 22, 2026Common StockSale400US$581.83331,559Indirect
Oct 22, 2026Common StockSale760US$583.09330,799Indirect
Oct 22, 2026Common StockSale1,200US$584.21329,599Indirect
Oct 22, 2026Common StockSale1,756US$585.24327,843Indirect
Oct 22, 2026Common StockSale1,280US$586.31326,563Indirect
Oct 22, 2026Common StockSale937US$587.24325,626Indirect
Oct 22, 2026Common StockSale783US$588.19324,843Indirect
Oct 22, 2026Common StockSale240US$589.50324,603Indirect
Oct 22, 2026Common StockSale160US$590.40324,443Indirect

Source

Download original · View original at SEC

Related